Yinka’s Blog: Digital Therapeutics: what next?
A big thank you to everyone who attended and contributed to the recent annual DigitalHealth.London/Collaborate Summit, which this year we hosted in collaboration with NHS England and IQVIA.
A big thank you to everyone who attended and contributed to the recent annual DigitalHealth.London/Collaborate Summit, which this year we hosted in collaboration with NHS England and IQVIA.
Delegates at DHL/Collaborate 2018, talk about the summit and digital therapeutics.
The first multi-stakeholder summit meeting, hosted by Digital Health.London, in collaboration with NHS England, IQVIA, and the Digital Therapeutics Alliance, brought together nearly 200 representatives from many aspects of healthcare and technology, to participate in an agenda which shone a spotlight on the rise of digital therapeutics, and examined the evidence that they work.
There are many contributing factors driving the quality of health outcomes. But one emerging question that is gaining traction and profile is, can digital therapeutics play a role in improving health outcomes, and what is the evidence to suggest they can?
As a preview to the DigitalHealth.London/Collaborate 2018 Summit: Digital Therapeutics in the NHS (London, UK; April 24, 2018), the authors outline how the UK could become a leader in the emerging digital therapeutics industry by creating the world’s first turnkey digital therapeutics research platform.
Ahead of the Digital Therapeutics in the NHS Summit (London, UK; April 24, 2018), this article examines the need for evidence of the value of digital therapeutics within the NHS.